Invention Grant
- Patent Title: Deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof
-
Application No.: US16333700Application Date: 2017-09-18
-
Publication No.: US10654851B2Publication Date: 2020-05-19
- Inventor: Yongqiang Zhu , Zhaogang Liu , Chao Feng , Shihe Hu , Hao Chen , Enhe Bai , Jie Wang , Jingmiao Shi
- Applicant: NANJING CHUANGTE PHARMACEUTICAL TECHNOLOGY CO., LTD
- Applicant Address: CN Nanjing
- Assignee: NANJING CHUANGTE PHARMACEUTICAL TECHNOLOGY CO., LTD.
- Current Assignee: NANJING CHUANGTE PHARMACEUTICAL TECHNOLOGY CO., LTD.
- Current Assignee Address: CN Nanjing
- Agency: CBM Patent Consulting, LLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6e7fcecc com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@54e3f0fd
- International Application: PCT/CN2017/102027 WO 20170918
- International Announcement: WO2018/050108 WO 20180322
- Main IPC: C07D471/06
- IPC: C07D471/06 ; A61P35/00 ; A61P35/02 ; A61K31/506 ; C07B59/00

Abstract:
A type of deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof. The derivatives are compounds of Formula (I) or pharmaceutically acceptable salts thereof. These compounds or salts thereof can be used for treatment or prevention of diseases or illnesses through certain mutant forms of epidermal growth factor receptors, inhibit the growth of various tumor cells effectively, and inhibit other proteases of EGFR and Her families, they can be used for preparing anti-tumor drugs.
Public/Granted literature
- US20190225610A1 DEUTERATED 3-(4,5-SUBSTITUTED AMINOPYRIMIDINE)PHENYL DERIVATIVES AND USE THEREOF Public/Granted day:2019-07-25
Information query